Universe Pharmaceuticals (UPC) Receivables - Net (2020 - 2025)

Universe Pharmaceuticals (UPC) has 6 years of Receivables - Net data on file, last reported at $13.0 billion in Q3 2025.

• For the quarter ending Q3 2025, Receivables - Net rose 0.79% year-over-year to $13.0 billion; the trailing twelve-month figure through Sep 2025 stood at $13.0 billion (up 0.79% YoY), and the FY2025 full-year result was $13.0 billion, up 0.79% from the prior year.
• Receivables - Net rose to $13.0 billion in Q3 2025, from $12.9 billion in the prior quarter.
• In the past five years, Receivables - Net ranged from a high of $13.0 billion in Q3 2025 to a low of $11.0 million in Q3 2023.
• A 5-year average of $3.3 billion and a median of $16.8 million in 2021 frame the typical range for Receivables - Net.
• Across the five-year window, Receivables - Net sank 31.05% in 2023 and jumped 117066.85% in 2024, its largest moves.
• Tracing UPC's Receivables - Net over 5 years: stood at $16.0 million in 2021, then retreated by 0.28% to $16.0 million in 2022, then sank by 31.05% to $11.0 million in 2023, then jumped by 117066.85% to $12.9 billion in 2024, then climbed by 0.79% to $13.0 billion in 2025.
• Business Quant data shows UPC's Receivables - Net at $13.0 billion in Q3 2025, $12.9 billion in Q3 2024, and $14.4 million in Q1 2024.